Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Fall Conference 2017


 
 

Date: Sep 16, 2017 08:00 AM - 05:00 PM

Location: JW Marriott Scottsdale Camelback Inn, 5402 East Lincoln Drive, Scottsdale, AZ, 85253

CE Hours

7.50

CE Units

0.750

Registration closes on Sep 20, 2017 12:00 PM

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians
  • Student

Accreditation(s)

Accreditation Council for Pharmacy Education
The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as providers of continuing education.

 

 

Registration closes on Sep 20, 2017 at 12:00 PM

Registration Closed  

Pharmacist Learning Objectives
1.  Recognize current statistics and future projections for type 2 diabetes mellitus (T2DM) in the southwest US, nationwide and worldwide.
2.  Describe practice tools to screen patients for prediabetes and identify strategies and resources to prevent or delay the onset of T2DM.
3.  Explain the pathophysiology, risk factors and diagnostic criteria of metabolic syndrome, as well as management strategies to reduce diabetes risk.
4.  Utilize current evidence-based guidelines as they relate to obesity screening, diagnosis, treatment, and individualization of care.
5.  Describe the mechanism of action, efficacy and safety of current drug classes as monotherapy and in combination.
6.  Review current evidence-based guidelines and apply individualized strategies for the use of novel antidiabetic agents including SGLT2s, incretins, insulins, and combination therapies.
 
Pharmacy Technician Learning Objectives
1. Recognize current statistic and future projections for type 2 diabetes mellitus (T2DM in the southwest US, nationwide and worldwide).
2.  Describe the pathophysiology and risk factors of metabolic syndrome, as well as strategies to reduce diabetes risk.
3.  Describe the efficacy and safety of current drug classes as monotherapy and in combination.
4.  Describe the novel antidiabetic agents including SGLT2s, incretins, insulins, and combination therapies used to treat diabetes.

Activity Number

0100-9999-17-053-L01-P
Date: 09/16/17
Time: 07:00 AM - 01:00 PM

CE Hours

4.50
Registration Closed  

Registration Closed  

Pharmacist Learning Objectives:
1.  Assess a patients's risk for atherosclerotic cardiovascular disease.
2.  Apply treatment guidelines for hypertension and dyslipidemia to the care of individual patients.
3.  Evaluate a patient's risk for T2DM.
4.  Using ADA guidelines, describe oral treatment options for T2DM.
5.  Utilize CDC and ACIP guidelines to recommend appropriate vaccinations for patient based on age, disease state(s), or medical condition(s).
6.  Describe necessity and timing for subsequent vaccine doses based on age or disease state.
7.  Identify medications or medical conditions that may limit a patient's ability to receive a vaccine.
8.  Describe Arizona's vaccine reporting system (ASIIS) and benefits/barriers to its use.
 
Pharmacy Technician Learning Objectives
1.  Describe how a pharmacist approaches patient assessment.
2.  Identify current treatment options for T2DM and cardiovascular disease.
3.  Identify current vaccinations available to prevent infectious diseases in patients.

Activity Number

0100-0000-17-055-L01-P
Date: 09/16/17
Time: 02:15 PM - 05:30 PM

CE Hours

3.00
Registration Closed